© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
November 28, 2015
Evidence-Based Diabetes Management
Results from the ELIXA trial were presented in June at the 75th Scientific Sessions of the American Diabetes Association.
November 26, 2015
The algorithm-driven system in the study was a step up from the improved technology that has reached the market in recent years, providing more consistent glucose control.
The weeks leading up to the release of the Dietary Guidelines for Americans have seen a series of reports on what kinds of diets work and attacks on the work that went into the report that informs the nation's nutrition policy.
November 25, 2015
A newly approved therapy offers the first new option in years to prevent hyperkalemia.
November 22, 2015
An Interview with Joslin's George King, MD
November 18, 2015
This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.
November 17, 2015
Research at the University of Tennessee Health Sciences could lead to human trials in the next 2 to 3 years.
November 16, 2015
Several clinical trials under way are examining whether a new class of therapy approved to treat type 2 diabetes can also treat type 1.
November 15, 2015
A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Employer policies for access to maximum benefits do not always match those for access to obesity therapy.
November 13, 2015
The nation's largest pharmacy benefits manager has presumably negotiated discounts to cover both cholesterol-lowering drugs.
Sanofi's vice president of Diabetes Integrated Care discusses the recent collaboration with Google.